Skip Navigation

JNCI Journal of the National Cancer Institute 2000 92(12):965; doi:10.1093/jnci/92.12.965
© 2000 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Newman, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Newman, L.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 92, No. 12, 965, June 21, 2000
© 2000 Oxford University Press

NEWS

Cancer Therapies Touted in Physician, Hospital, Web Advertising

Laura Newman

Besides the flurry of direct-to-consumer marketing by drug and device manufacturers, many physicians and hospitals are energetically marketing avant garde cancer care. They are not exempt from criticism.

Patients with prostate cancer avidly seek out treatments that can protect them from well-publicized . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?